多平面L形瘢痕隆胸提乳术:针对肌肉、腺体组织和皮肤的个体化方法
本文描述一种无需复杂标记、按平面操作的多平面L形瘢痕隆胸提乳术式。回顾性观察研究纳入2016年1月至2021年7月接受手术的632例女性,平均年龄38岁(范围18至71岁),平均假体体积285 cc(范围175至550 cc),均为圆形纳米纹理表面假体,每侧乳房平均切除组织117 g(范围5至550 g),随访12至84个月,并发症总计19.30%,其中轻微并发症10.44%、主要并发症8.86%。作者认为该技术用途广泛、安全且结果可预测,并发症与其他已确立技术相似。
要点
- 632例女性接受多平面L形瘢痕隆胸提乳术,平均年龄38岁,平均假体体积285 cc。
- 每侧乳房平均切除组织117 g,随访12至84个月,并发症总计19.30%。
- 轻微并发症10.44%,主要并发症8.86%,作者称并发症与其他已确立技术相似。
核心结论
- 多平面L形瘢痕提乳术是一种用途广泛、安全且结果可预测的技术,可系统处理最多样的乳房类型,并发症与其他已描述并确立的技术相似。
研究设计与样本
- 回顾性观察研究,基于作者本人系列病例,描述术前就诊及按皮肤、腺体组织、肌肉三个组成部分分步的手术技术。
- 2016年1月至2021年7月共632例女性接受手术,平均年龄38岁(范围18至71岁)。
主要发现
- 平均假体体积285 cc(范围175至550 cc),所有假体均为圆形纳米纹理表面。
- 每侧乳房平均切除组织117 g(范围5至550 g)。
- 随访12至84个月,术后30天起进行照片记录。
- 并发症总计19.30%,轻微并发症10.44%(予期待治疗、无创处理或可在局部麻醉下矫正),主要并发症8.86%(需返回手术室)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Augmentation mastopexy focuses on restoring the youthful appearance of the female breast. Despite those benefits, there is large scarring to be considered, and the reduction of this side effect is the main goal to enhance the aesthetic result. This article aims to describe a variation of the L-shaped mastopexy technique without complex marking and performed in planes, which improves long-term results for patients undergoing this approach. METHODS: This is a retrospective, observational study, based on a series of cases conducted by the author. The preoperative appointment and the surgical technique are described and divided into steps according to their components: cutaneous, glandular tissue, and muscular. RESULTS: Between January of 2016 and July of 2021, 632 women underwent surgery. The mean age was 38 years (range, 18 to 71 years). The mean volume of implants was 285 cc (range, 175 to 550 cc). All the implants used were round with a nanotextured surface. The mean amount of tissue resected from each breast was 117 g (range, 5 to 550 g). Follow-ups ranged from 12 to 84 months, and photographic documentation was performed from 30 days after surgery. Complications totaled 19.30% and were divided into minor [treated with expectant treatment, noninvasive, or with the possibility of correction with local anesthesia (10.44%)] and major [in which it was necessary to return to the operating room (8.86%)]. CONCLUSIONS: Multiplane L-scar mastopexy is a versatile and safe technique with predictable results, which allows the systematic treatment of the most diverse breast types, with complications similar to other already described and solidified techniques. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Bark AA, Minikowski GC, Mujahed IBU, et al. Multiplane L-Scar Augmentation Mastopexy: An Individualized Approach to Muscle, Glandular Tissue, and Skin. Plast Reconstr Surg. 2023. PMID: 37335763. doi:10.1097/PRS.0000000000010850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。